Pathologic findings:
Consists of a partially cut open right kidney with the perirenal fat
weighing 350 gm and measuring 10.0x6.0x4.0 cm in dimension. A segment of
grossly normal ureter measuring 7.0 cm and the adrenal gland are also included.
Complete cut surface shows a yellowish tumour measuring 3.5x3.5 cm at the
middle part of the kidney. This had partly bulged onto the renal surface
but the capsule appears intact grossly. The renal hilum shows no enlarged
nodes or involvement of the renal pelvis.
| Gross appearance of cut surface. | Closer view of tumour. |
Sections show a tumour with a rather uniform appearance throughout.
It consists of diffuse sheets and nests of malignant epithelial cells with
a 'hypernephroid' appearance. These cells form small solid clusters. They
have small round nuclei and abundan clear cytoplasm. The tumour stroma
is congested and focally haemorrhagic. Several microgranulomata are seen
within the tumour, accompanied by foreign body and Langhan's type giant
cells. The edge of the tumour also show focal dense chronic inflammatory
infiltrate. No vascular invasion is found. Although the renal capsule is
stretched very thin by the tumour, the capsule appears intact and there
is no perirenal fat infiltration. However a small granuloma is seen in
the perirenal fat apparently not associated with tumour tissues. The ureter
shows no tumour involvement. The adrenal glands is normal. The perihilar
fat shows no lymph node. The residual renal parenchyma shows no further
pathology.
| Figure 1: Capsule area, low power view | Figure 2: Capsule area, higher power view. | Figure 3: Tumour low power view. |
| Figure 4: Tumour low power view. | Figure 5: Tumour high power view. | Figure 6: Granuloma |
Pathologic Diagnosis:
Right kidney - Renal cell carcinoma. Renal capsule appears intact. No vascular invasion seen.
Pathologist Comments:
Renal cell carcinoma is a tumour differentiating towards the renal tubular epithelium and is thus a form of adenocarcinoma. It generally arises in the adult or elderly with a slight predilection for male (M:F ratio varing from 2:1 to 3:1). It rarely arises in childhood and in this age group, the tumour need to be carefully distinguished from clear cell sarcoma of the kidney which is a very aggressive tumour. Rare familial cases are associated with the von Hippel-Lindau disease.
Renal cell carcinoma is known for some interesting peculiarities:
Grossly, most tumours are well circumscribed, often protruding as an apparently extrarenal mass. Cut surfaces are typically solid bright yellowish, with haemorrhages, necrosis and myxoid changes resulting in a typical variegated appearance. Some cases are predominantly or entirely cystic and diagnosis can only be confirmed by extensive microscopic examination of the cyst wall.
Tumour cells generally have two appearances: clear cell and granular. The former appearance is due to cytoplasmic accumulation of glycogen and fat and is not due to mucin production. They look like 'vegetable cells'. The tumour is graded based on nuclear features but this is subjective. Other histological types include papillary tumours, chromophobe cell type carcinoma, collecting duct carcinoma and sarcomatoid renal cell carcinoma. The significance of the granulomas in this patient is unknown. It is possibly related to some products or proteins produced by the tumour cells.
The tumour cells expresses various epithelial markers, and in addition, vimentin. A host of other enzymes, proteins and hormones had also been detected, possibly related to the fact that they differentiate in the direction of proximal renal tubular cells. Non-papillary types of tumours often have terminal deletion of the short arm of chromosome 3.
Prognostic factors:
| Stage | Description | 5-year survival |
| Stage I | Confined to the kidney. | 60-80% |
| Stage II | Extension to perirenal fat but within Gerota's fascia | 40-70% |
| Stage III | Renal vein or vena caval involvement, or regional lymph node metastases | 10-40% |
| Stage IV | Extension to adjacent organs other than adrenal, or distant metastases | <5% |
Reference: